Nutanix, Inc.
For the period ended Jul 31, 2025. Filed Sep 24, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Sep 24, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements Note 1: Overview and Summary of Significant Accounting Policies
NOTE 1. OVER VIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Organization and Description of Business
Nutanix, Inc. was incorporated in the state of Delaware in September 2009. Nutanix, Inc. is headquartered in San Jose, California, and together with its wholly-owned subsidiaries (collectively, "we," "us," "our," or "Nutanix"), has operations throughout North America, Europe, Asia Pacific, the Middle East, Latin America, and Africa.
We are a hybrid multicloud computing leader, offering organizations a unified software platform for running applications and AI and managing data anywhere. Our vision is to simplify the deployment and operation of the increasingly distributed landscape of apps and data while freeing organizations to focus on business goals. Our mission is to delight customers with an open, secure platform with rich data services that increases their ability to take advantage of new technologies such as cloud native and AI, optimizes how they run their organizations today, and accelerates innovation, efficiency, and growth.
The Nutanix Cloud Platform is designed to enable organizations to build hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, while supporting customer choice across server platforms, storage options, public and managed clouds, and container and virtualization platforms. The Nutanix Cloud Platform supports a wide variety of workloads with varied compute, storage, and network requirements, including business-critical applications, data platforms (including SQL, NoSQL, and vector databases and business intelligence applications), enterprise AI workloads (including machine learning, generative AI, and agentic AI), general-purpose workloads (including system infrastructure, networking, and security), and end-user computing and virtual desktop infrastructure services, and cloud native applications (including modern, containerized applications).
Our business is organized into a single operating and reportable segment. Our subscription-based business model provides our customers with the flexibility to choose their preferred license levels and durations based on their specific business needs. A subscription-based business model means one in which our products, including associated support and entitlement arrangements, are sold with a defined duration. Our solutions are primarily sold through channel partners and original equipment manufacturers ("OEMs") (collectively, "Partners") and delivered directly to our end customers.
Principles of Consolidation
The accompanying consolidated financial statements, which include the accounts of Nutanix, Inc. and its wholly-owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP"). All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Such management estimates and assumptions include, but are not limited to, the best estimate of selling prices for products and related support; useful lives and recoverability of intangible assets and property and equipment; allowance for credit losses; determination of fair value of stock-based awards; accounting for income taxes, including the valuation allowance on deferred tax assets and uncertain tax positions; purchase commitment liabilities to our contract manufacturers; sales commissions expense and the period of benefit for deferred commissions; whether an arrangement is or contains a lease; the incremental borrowing rate to measure the present value of right-of-use assets and lease liabilities; and contingencies and litigation. Management evaluates these estimates and assumptions on an ongoing basis using historical experience and other factors and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Concentration of Risk
Credit Risk — Financial instruments that potentially subject us to concentrations of credit risk consist of cash and cash equivalents and accounts receivable. We invest only in high-quality credit instruments and maintain our cash and cash equivalents and available-for-sale investments in fixed income securities. Management believes that the financial institutions that hold our investments are financially sound and, accordingly, are subject to minimal credit risk. Our deposits are with multiple institutions, however such deposits may exceed federally insured limits. We provide credit, in the normal course of business, to a number of companies and perform credit evaluations of our customers.
Concentration of Revenue and Accounts Receivable — We sell our products primarily through our Partners and occasionally directly to end customers. For the fiscal years ended July 31, 2023, 2024 and 2025, no end customer accounted for more than 10% of total revenue or accounts receivable.
For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows:
| Revenue · Accounts Receivable as of | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Year Ended July 31, · July 31,2024 · July 31,2025 | |||||||||
| Partners · 2023 · 2024 · 2025 | |||||||||
| Partner A | 16% | 16% | 15% | 10% | 14% | ||||
| Partner B | (1) | (1) | 16% | 16% | 13% | ||||
| Partner C | 32% | 31% | 25% | 12% | (1) | ||||
| Partner D | 10% | 11% | 10% | (1) | (1) | ||||
(1)
Less than 10%
Summary of Significant Accounting Policies
Cash, Cash Equivalents and Short-Term Investments
We classify all highly liquid investments with original maturities of three months or less from the date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months as marketable securities.
We determine the appropriate classification of our marketable securities at the time of purchase and reevaluate such designation as of each balance sheet date. We classify and account for our marketable securities as available-for-sale securities. We classify our marketable securities with stated maturities greater than twelve months as short-term investments due to our intent and ability to use these securities to support our current operations.
Our marketable securities are recorded at their estimated fair value. Unrealized gains or losses on available-for-sale securities are reported in other comprehensive income (loss). We periodically review whether our securities may be other-than-temporarily impaired, including whether or not (i) we have the intent to sell the security or (ii) it is more likely than not that we will be required to sell the security before its anticipated recovery. If one of these factors is met, we will record an impairment loss associated with our impaired investment. The impairment loss will be recorded as a write-down of investments in our consolidated balance sheets and a realized loss within other expense in our consolidated statements of operations.
Fair Value Measurement
We define fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, we consider the principal or most advantageous market in which to transact and the market-based risk. We apply fair value accounting for all assets and liabilities that are recognized or disclosed at fair value in our consolidated financial statements on a recurring basis. The carrying amounts reported in our consolidated financial statements for cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities approximate their fair values due to their short-term nature. The fair value of the outstanding 0.25% convertible senior notes due 2027 (the "2027 Notes") is determined based on the closing trading price per $100 of the 2027 Notes as of the last day of trading for the period. The fair value of the outstanding 0.50% convertible senior notes due 2029 (the "2029 Notes") is determined based on the closing trading price per $100 of the 2029 Notes as of the last day of trading for the period.
Convertible Senior Notes
Our convertible senior notes, including any embedded conversion features, are accounted for under the convertible debt accounting model and are treated as a liability, net of unamortized issuance costs. The carrying amount of the liability is classified as a current liability if we have committed to settle with current assets; otherwise, it is classified as a long-term liability, as we retain the option to settle conversion requests in shares of our Class A common stock. The embedded conversion features are not remeasured as long as they do not meet the separation requirement of a derivative; otherwise, they are classified as derivative instruments and accounted for as such. Issuance costs are amortized to interest expense using the effective interest rate method over the term of the notes. In accounting for a holder’s exercise in accordance with a note’s original conversion terms of a conversion option for which the carrying amount has previously been reclassified to equity, any unamortized discount remaining at the date of conversion is first recognized as interest, and then the remaining carrying amount of the converted notes is reduced by the cash transferred and then recognized in equity to reflect the shares issued, such that no gain or loss is recognized. In accounting for extinguishments of the notes, the reacquisition price of the extinguished notes is compared to the carrying amount of the respective extinguished notes and a gain or loss is recorded in other expense, net on our consolidated statements of operations.
Accounts Receivable and Allowance for Credit Losses
Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. Credit is extended to customers based on an evaluation of their financial condition and other factors. We generally do not require collateral or other security to support accounts receivable. We perform ongoing credit evaluations of our customers and maintain an allowance for credit losses.
The allowance for credit losses is based on the best estimate of the amount of probable credit losses in existing accounts receivable. We assess credit losses on accounts receivable by taking into consideration past collection experience, the credit quality of the customer, the age of the receivable balance, current and future economic conditions, and forecasts that may affect the collectibility of the reported amount. In circumstances where we are aware of a specific customer’s inability to meet its financial obligations (e.g., bankruptcy filings or substantial downgrading of credit ratings), we record an allowance for credit losses in order to reduce the net recognized receivable to the amount we reasonably believe will be collected. For all other customers, we record an allowance for credit losses based on the length of time the receivable is past due and our historical experience of collections and write-offs.
The changes in the allowance for credit losses are as follows:
| Fiscal Year Ended July 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| (in thousands) | |||
| Allowance for credit losses—beginning balance | $644 | $733 | $772 |
| Charged to allowance for credit losses | 212 | 830 | 1,415 |
| Recoveries | (123) | — | — |
| Write-offs | — | (791) | — |
| Allowance for credit losses—ending balance | $733 | $772 | $2,187 |
Property and Equipment
Property and equipment, including leasehold improvements, are stated at cost, less accumulated depreciation and amortization. We include the cost to acquire demonstration units and the related accumulated depreciation in property and equipment as such units are generally not available for sale. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the related assets.
Leases
We determine if an arrangement is or contains a lease at inception by evaluating various factors, including whether a vendor’s right to substitute an identified asset is substantive. Lease classification is determined at the lease commencement date when the leased assets are made available for our use. Operating leases are included in operating lease right-of-use assets, operating lease liabilities—current and operating lease liabilities—non-current in our consolidated balance sheets. Finance leases are included in property and equipment, net, accrued expenses and other current liabilities and other liabilities—non-current in our consolidated balance sheets.
Right-of-use assets ("ROU assets") represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make payments arising from the lease. ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease payments consist primarily of fixed payments under the arrangement, less any lease incentives, such as rent holidays. Variable lease payments not dependent on an index or a rate are expensed as incurred and are not included within the ROU asset and lease liability calculation. Variable lease payments primarily include reimbursements of costs incurred by lessors for common area maintenance, property taxes and utilities. We use an estimate of our incremental borrowing rate ("IBR") based on the information available at the lease commencement date in determining the present value of lease payments, unless the implicit rate is readily determinable. In determining the appropriate IBR, we consider information including, but not limited to, our credit rating, the lease term and the currency in which the arrangement is denominated. Our lease terms may include renewal options, which are not included in the lease terms for calculating our lease liability, unless we are reasonably certain that we will exercise the renewal option at the time of the lease commencement. Lease costs are recognized on a straight-line basis as operating expenses within our consolidated statements of operations. We present lease payments within cash flows from operations within our consolidated statements of cash flows.
For our operating leases, we account for lease and non-lease components as a single lease component. Additionally, we do not record leases on our consolidated balance sheet that have a lease term of 12 months or less at the lease commencement date.
Goodwill, Intangible Assets and Other Long-Lived Assets
Goodwill represents the future economic benefits arising from other assets acquired in a business combination or an acquisition that are not individually identified and separately recorded. The excess of the purchase price over the estimated fair value of net assets of businesses acquired in a business combination is recognized as goodwill.
Intangible assets consist of identifiable intangible assets, including developed technology, customer relationships and trade names, resulting from business combinations. Finite-lived intangible assets are recorded at fair value, net of accumulated amortization. Finite-lived intangible assets are amortized on a straight-line basis over their estimated useful lives. Amortization expense is included as a component of cost of product revenue and sales and marketing expense in our consolidated statements of operations. Amounts included in sales and marketing expense relate to customer relationships and trade names.
Goodwill and other intangible assets acquired in a business combination and determined to have an indefinite useful life are not amortized, but instead tested for impairment at least annually, in the fourth quarter of each fiscal year. Such goodwill and other intangible assets may also be tested for impairment between annual tests in the presence of impairment indicators such as, but not limited to: (i) a significant adverse change in legal factors or in the business climate; (ii) a substantial decline in our market capitalization; (iii) an adverse action or assessment by a regulator; (iv) unanticipated competition; (v) loss of key personnel; (vi) a more likely-than-not expectation of the sale or disposal of a reporting unit or a significant portion thereof; (vii) a realignment of our resources or restructuring of our existing businesses in response to changes to industry and market conditions; (viii) testing for recoverability of a significant asset group within a reporting unit; or (ix) a higher discount rate used in the impairment analysis as impacted by an increase in interest rates.
Goodwill is tested for impairment by comparing the reporting unit's carrying value, including goodwill, to the fair value of the reporting unit. We operate under one reporting unit and for our annual goodwill impairment test, we determine the fair value of our reporting unit based on our enterprise value. We may elect to utilize a qualitative assessment to determine whether it is more likely than not that the fair value of our reporting unit is less than its carrying value. If, after assessing the qualitative factors, we determine that it is more likely than not that the fair value of our reporting unit is less than its carrying value, an impairment analysis will be performed. We compare the fair value of our reporting unit with its carrying amount and if the carrying value of the reporting unit exceeds its fair value, an impairment loss will be recognized.
Long-lived assets, such as property and equipment and finite-lived intangible assets subject to depreciation and amortization, are evaluated for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Among the factors and circumstances we consider in determining recoverability are: (i) a significant decrease in the market price of a long-lived asset; (ii) a significant adverse change in the extent or manner in which a long-lived asset is being used or in its physical condition; (iii) a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset, including an adverse action or assessment by a regulator; (iv) an accumulation of costs significantly in excess of the amount originally expected for the acquisition; and (v) current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated with the use of a long-lived asset. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.
There have beenno indicators of impairment of goodwill, intangible assets or other long-lived assets and we did not record any material impairment losses during fiscal 2023, 2024 or 2025.
Revenue Recognition
The core principle of ASC 606 is to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. This principle is achieved by applying the following five-step approach:
Identification of the contract, or contracts, with a customer — A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods or services to be transferred and identifies the payment terms related to these goods or services, (ii) the contract has commercial substance and (iii) we determine that collection of substantially all consideration for goods or services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.
Identification of the performance obligations in the contract —Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the goods or services either on their own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised goods or services, we apply judgment to determine whether promised goods or services are capable of being distinct and distinct in the context of the contract. If these criteria are not met, the promised goods or services are accounted for as a combined performance obligation.
Determination of the transaction price — The transaction price is determined based on the consideration to which we will be entitled in exchange for transferring goods or services to the customer.
Allocation of the transaction price to the performance obligations in the contract— If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price ("SSP"). We determine SSP based on the price at which the performance obligation is sold separately. If the SSP is not observable through past transactions, we estimate the SSP, taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.
Recognition of revenue when, or as, performance obligations are satisfied — We satisfy performance obligations either over time or at a point in time. Revenue is recognized at the time the related performance obligation is satisfied with the transfer of a promised good or service to a customer. For additional details on revenue recognition, refer to Note 2 of Notes to Consolidated Financial Statements.
Contracts with multiple performance obligations— The majority of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative SSP basis. For deliverables that we routinely sell separately, such as software entitlement subscriptions and support subscriptions on our core offerings, we determine SSP by evaluating the standalone sales over the trailing 12 months. For those that are not sold routinely, we determine SSP based on our overall pricing trends and objectives, taking into consideration market conditions and other factors, including the value of our contracts, the products sold, and geographic locations.
Contract balances —The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. A receivable is recognized in the period in which we deliver goods or provide services, or when our right to consideration is unconditional. This includes situations where revenue recognition occurs before invoicing and an unbilled receivable is created. The balance of unbilled accounts receivable, included in accounts receivable, net on our consolidated balance sheets, was $41.1 million and$83.5 million as of July 31, 2024 and 2025, respectively.
Our customers are typically invoiced upfront, including invoices for multi-year subscriptions, with payment terms of 30-45 days. We assess credit losses on accounts receivable by taking into consideration past collection experience, the credit quality of the customer, the age of the receivable balance, current and future economic conditions, and forecasts that may affect the collectability of the reported amount. The balance of accounts receivable, net of allowance for credit losses, as of July 31, 2024 and 2025 is presented in the accompanying consolidated balance sheets.
Costs to obtain and fulfill a contract —We capitalize commissions paid to sales personnel and the related payroll taxes when customer contracts are signed. These costs are recorded as deferred commissions in our consolidated balance sheets, current and non-current. We determine whether costs should be deferred based on our sales compensation plans if the commissions are incremental and would not have been incurred absent the execution of the customer contract. Commissions paid upon the initial acquisition of a contract are recognized over the estimated period of benefit, which may exceed the term of the initial contract if the commissions expected to be paid upon renewal are not commensurate with that of the initial contract. Accordingly, deferred costs are recognized on a systematic basis that is consistent with the pattern of revenue recognition allocated to each performance obligation over the entire period of benefit and included in sales and marketing expense in our consolidated statements of operations. We determine the estimated period of benefit by evaluating the expected renewals of customer contracts, the duration of relationships with our customers, customer retention data, our technology development lifecycle, and other factors. Deferred costs are periodically reviewed for impairment.
Taxes assessed by a government authority that are both imposed on and concurrent with specific revenue transactions between us and our customers are presented on a net basis in our consolidated statements of operations.
Deferred revenue — Deferred revenue primarily consists of amounts that have been invoiced but not yet recognized as revenue and primarily pertains to software entitlement subscriptions, support subscriptions and professional services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the consolidated balance sheet date.
Cost of Revenue
Cost of revenue consists of cost of product revenue and cost of support, entitlements and other services revenue. Personnel costs associated with our operations and global customer support organizations consist of salaries, benefits and stock-based compensation. Allocated costs consist of certain facilities, depreciation and amortization, recruiting, and information technology costs, allocated based on headcount.
Warranties
We generally provide a 90-day warranty on software licenses which provides for bug fixes. With respect to hardware, we have a warranty agreement with our contract manufacturers under which the OEMs are generally required to replace defective hardware within three years of shipment. Furthermore, our post-contract customer support ("PCS") agreements provide for the same parts replacement that customers are entitled to under the warranty program, except that replacement parts are delivered according to targeted response times to minimize disruption to the customers’ critical business applications. Substantially all customers purchase PCS agreements.
Given the warranty agreement with our OEMs and considering that substantially all products are sold together with PCS agreements, we generally have very limited exposure related to warranty costs and therefore no warranty reserve has been recognized.
Research and Development
Our research and development expense consists primarily of product development personnel costs, including salaries and benefits, stock-based compensation and allocated facilities, IT, and recruiting costs. Research and development costs are expensed as incurred. Currently, we expense software development costs as incurred, as from the inception of the product development, our software products are primarily intended to be marketed and sold to customers on-premises, either standalone and/or with other product offerings.
Stock-based compensation expense is measured based on the grant date fair value of share-based awards. The fair value of the purchase rights under our 2016 Employee Stock Purchase Plan ("2016 ESPP") is estimated using the Black-Scholes-Merton ("Black-Scholes") option pricing model, which is impacted by the fair value of our common stock, as well as changes in assumptions regarding a number of subjective variables. These variables include the expected common stock price volatility over the term of the awards, the expected term of the awards, risk-free interest rates, and expected dividend yield. The fair value of restricted stock units ("RSUs") is determined using the fair value of our common stock on the date of grant. The fair value of awards with a market-based condition is measured using a Monte Carlo simulation, which requires the use of various assumptions, including the stock price volatility and risk-free interest rate as of the valuation date corresponding to the length of time remaining in the performance period and expected dividend yield.
We grant stock awards with service conditions only and with both service and performance or market-based conditions. We recognize stock-based compensation expense for employee stock awards with a service condition only using the straight-line method over the requisite service period of the awards, which is generally the vesting period. We use the graded vesting attribution method to recognize stock-based compensation expense related to employee stock awards that contain both service and performance or market-based conditions. The fair value of the 2016 ESPP purchase rights is recognized as expense on a straight-line basis over the offering period. We account for forfeitures of all share-based awards when they occur.
Foreign Currency
The functional currency of our foreign subsidiaries is the U.S. dollar. Transactions denominated in currencies other than the functional currency are remeasured at the average exchange rate in effect during the reporting period. At the end of each reporting period all monetary assets and liabilities of our subsidiaries are remeasured at the current U.S. dollar exchange rate at the end of the reporting period. Remeasurement gains and losses are included within other expense, net in our consolidated statements of operations. During the fiscal years ended July 31, 2023, 2024 and 2025, we recognized foreign currency losses of $1.6 million, $4.3 million and $0.9 million, respectively. To date, we have not undertaken any hedging transactions related to foreign currency exposure, but we may do so in the future if our exposure to foreign currency should become more significant. As our international operations grow, we will continue to reassess our approach to managing our risk relating to fluctuations in currency rates.
Segments
Our chief operating decision maker is our Chief Executive Officer. This individual allocates resources and assesses financial performance based upon discrete financial information at the consolidated level. Accordingly, we have determined that we operate as a single operating and reportable segment. For additional details, refer to Note 13 of Notes to Consolidated Financial Statements.
We account for income taxes using the asset and liability method. Deferred income taxes are recognized by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance on amounts that are more likely than not to be realized.
We record a liability for uncertain tax positions if it is not more likely than not to be sustained based solely on its technical merits as of the reporting date. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments and may not accurately anticipate actual outcomes.
Advertising Costs
Advertising costs are charged to sales and marketing expense as incurred in our consolidated statements of operations. During the fiscal years ended July 31, 2023, 2024 and 2025, advertising expense was $11.6 million, $14.7 million and $15.6 million, respectively.
Frame Divestiture
In May 2023, we sold our Frame Desktop-as-a-Service business. As consideration for the sale, the buyer paid $7.0 million in cash, adjusted by increases for the closing cash balance of the Frame business and the amount by which the closing working capital exceeded the working capital target and reductions for closing expenses, the amount by which the closing working capital target exceeded the working capital, and any severance expenses associated with Frame employees who were terminated at or following the close of the transaction at the direction of the buyer, and a $5.0 million interest-bearing convertible note, which had a fair value of $5.7 million as of the closing date of the transaction. The fair value of all consideration received exceeded the carrying amount of the Frame business upon closing, resulting in a gain of $11.0 million, which is included within other expense, net in our consolidated statement of operations for the fiscal year ended July 31, 2023.
Recently Adopted Accounting Pronouncements
In November 2024, the Financial Accounting Standards Board (the "FASB") issued accounting standards update ("ASU") 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. We early adopted the new standard during the fiscal quarter ended January 31, 2025 and applied it on a prospective basis.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires disclosure of incremental segment information on an annual and interim basis. We adopted this standard during the fiscal quarter ended July 31, 2025 and applied it on a fully retrospective basis.
Recently Issued and Not Yet Adopted Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which provides for improvements to income tax disclosures. The standard requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. The amendments in this update are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. This new ASU will be effective for us beginning in fiscal 2026. We do not expect this new standard to have a material impact on our disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the statement of operations. This new ASU is effective for fiscal years beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. This new ASU will be effective for us beginning in fiscal 2028. We are currently evaluating the impact this new standard will have on our disclosures.
NOTE 2. REVENUE, DEFERRED REVENUE AND DEFERRED COMMISSIONS
Disaggregation of Revenue and Revenue Recognition
The Nutanix Cloud Platform can be deployed in core data centers, at the edge, or in public clouds, running on a variety of qualified hardware platforms (including out Nutanix-branded NX hardware line), in popular public cloud environments such as Amazon Web Services and Microsoft Azure through Nutanix Cloud Clusters, or, in the case of our cloud-based software and software-as-a-service ("SaaS") offerings, via hosted service. Our subscription term-based licenses are sold separately, or can also be sold alongside configured-to-order servers. Our subscription term-based licenses typically have durations ranging fromone tofive years. Our cloud-based SaaS subscriptions generally have durations extending up to five years.
The following table depicts the disaggregation of revenue by revenue type, consistent with how we evaluate our financial performance:
| Fiscal Year Ended July 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| (in thousands) | |||
| Subscription | $1,730,848 | $2,016,776 | $2,410,751 |
| Professional services | 91,841 | 100,852 | 112,202 |
| Other non-subscription product | 40,206 | 31,188 | 14,974 |
| Total revenue | $1,862,895 | $2,148,816 | $2,537,927 |
Subscription revenue — Subscription revenue includes any performance obligation which has a defined duration and is generated from the sales of software entitlement subscriptions, support subscriptions, subscription software licenses and cloud-based SaaS offerings.
Ratable —We recognize revenue from software entitlement subscriptions, support subscriptions and SaaS offerings ratably over the contractual service period, the substantial majority of which relate to software entitlement subscriptions and support subscriptions. These offerings represented approximately$905.8 million,$1,029.0 million and$1,138.4 million of our subscription revenue for fiscal 2023, 2024 and 2025, respectively.
Upfront —Revenue from our subscription software licenses is generally recognized upfront upon transfer of control to the customer, which happens when we make the software available to the customer. These subscription software licenses represented approximately$825.0 million,$987.8 million and$1,272.4 million of our subscription revenue for fiscal 2023, 2024 and 2025, respectively.
Professional services revenue —We also sell professional services with our products. We recognize revenue related to professional services as they are performed.
Other non-subscription product revenue —Other non-subscription product revenue includes approximately $37.4 million, $27.9 million and $10.8 million of non-portable software revenue for fiscal 2023, 2024 and 2025, respectively, and approximately $2.8 million, $3.3 million and $4.2 million of hardware revenue for fiscal 2023, 2024 and 2025, respectively.
Non-portable software revenue —Non-portable software revenue includes sales of our platform when delivered on a configured-to-order server by us or one of our OEM partners. The software licenses associated with these sales are typically non-portable and can be used over the life of the server on which the software is delivered. Revenue from our non-portable software products is generally recognized upon transfer of control to the customer.
Hardware revenue —In the infrequent transactions where the hardware platform is purchased directly from Nutanix, we consider ourselves to be the principal in the transaction and we record revenue and costs of goods sold on a gross basis. We consider the amount allocated to hardware revenue to be equivalent to the cost of the hardware procured. Hardware revenue is generally recognized upon transfer of control to the customer.
Significant changes in the balance of deferred revenue (contract liability) and deferred commissions (contract cost asset) for the periods presented are as follows:
| DeferredRevenue | DeferredCommissions | |
|---|---|---|
| (in thousands) | ||
| Balance as of July 31, 2023 | $1,595,032 | $357,991 |
| Additions (1) | 2,426,490 | 218,876 |
| Revenue/commissions recognized | (2,148,816) | (218,056) |
| Balance as of July 31, 2024 | 1,872,706 | 358,811 |
| Additions (1) | 2,777,975 | 228,378 |
| Revenue/commissions recognized | (2,537,927) | (244,896) |
| Balance as of July 31, 2025 | $2,112,754 | $342,293 |
(1)
Includes both billed and unbilled amounts.
During the fiscal year ended July 31, 2024, we recognized revenue of approximately $771.2 million pertaining to amounts deferred as of July 31, 2023. During the fiscal year ended July 31, 2025, we recognized revenue of approximately $863.1 million pertaining to amounts deferred as of July 31, 2024.
Many of our contracted but not invoiced performance obligations are subject to cancellation terms. Revenue allocated to remaining performance obligations represents contracted revenue that has not yet been recognized ("contracted not recognized"), which includes deferred revenue and non-cancelable amounts that will be invoiced and recognized as revenue in future periods and excludes performance obligations that are subject to cancellation terms. Contracted not recognized revenue was approximately $2,692.6 million as of July 31, 2025, of which we expect to recognize approximately 49% within 12 months, approxim ately 36% over the subsequent 13- to 36-month period, and the remainder thereafter.
NOTE 3. FAIR VALUE MEASUREMENTS
The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy based on the observability of the inputs available in the market used to measure fair value as follows:
Level I— Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;
Level II— Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and
Level III— Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.
Assets Measured at Fair Value on a Recurring Basis
Cash Equivalents and Short-Term Investments
Our money market funds are classified within Level I due to the highly liquid nature of these assets and have unadjusted inputs, quoted prices in active markets for these assets at the measurement date from the financial institution that carries these investment securities. Our investments in available-for-sale debt securities such as commercial paper, corporate bonds and U.S. government securities are classified within Level II. The fair value of these securities is priced by using inputs based on non-binding market consensus prices that are corroborated by observable market data, quoted market prices for similar instruments, or pricing models such as discounted cash flow techniques.
Convertible Note Receivable
In May 2023, we sold our Frame Desktop-as-a-Service business. As part of the consideration for the sale, we received a $5.0 million interest-bearing convertible note. We have elected the fair value option for the convertible note and will record the changes in its fair value at each reporting period. As of July 31, 2025, the fair value of the convertible note was determined to be approxim ately $5.5 million. We cons ider this convertible note to be classified within Level III. The fair value is determined by considering the convertible note’s principal and accrued interest, as well as the convertible note’s option to convert into equity securities, using inputs including debt yields, volatility data, and the value of the underlying equity into which the convertible note could be converted.
The fair value of our financial assets measured on a recurring basis is as follows:
| Level I · Level II · Level III · Total | |||||
|---|---|---|---|---|---|
| (in thousands) | |||||
| Financial Assets, Current: | |||||
| Cash equivalents: | |||||
| Money market funds | $352,295 | $— | $— | $352,295 | |
| U.S. Government securities | — | 99 | — | 99 | |
| Commercial paper | — | 1,747 | — | 1,747 | |
| Short-term investments: | |||||
| Corporate bonds | — | 233,065 | — | 233,065 | |
| Commercial paper | — | 33,770 | — | 33,770 | |
| U.S. Government securities | — | 72,237 | — | 72,237 | |
| Total measured at fair value | $352,295 | $340,918 | $— | $693,213 | |
| Cash | 301,129 | ||||
| Total cash, cash equivalents and short-term investments | $994,342 | ||||
| Financial Assets, Non-Current: | |||||
| Convertible note receivable | $— | $— | $5,150 | $5,150 | |
| Level I · Level II · Level III · Total | |||||
|---|---|---|---|---|---|
| (in thousands) | |||||
| Financial Assets, Current: | |||||
| Cash equivalents: | |||||
| Money market funds | $371,762 | $— | $— | $371,762 | |
| U.S. Government securities | — | 21,703 | — | 21,703 | |
| Commercial paper | — | 13,068 | — | 13,068 | |
| Short-term investments: | |||||
| Corporate bonds | — | 647,074 | — | 647,074 | |
| Commercial paper | — | 163,055 | — | 163,055 | |
| U.S. Government securities | — | 413,105 | — | 413,105 | |
| Total measured at fair value | $371,762 | $1,258,005 | $— | $1,629,767 | |
| Cash | 362,969 | ||||
| Total cash, cash equivalents and short-term investments | $1,992,736 | ||||
| Financial Assets, Non-Current: | |||||
| Convertible note receivable | $— | $— | $5,460 | $5,460 | |
Financial Instruments Not Recorded at Fair Value on a Recurring Basis
We report our financial instruments at fair value, with the exception of the 2027 Notes and 2029 Notes (collectively, the "Notes"). Financial instruments that are not recorded at fair value on a recurring basis are measured at fair value on a quarterly basis for disclosure purposes. The carrying values and estimated fair values of financial instruments not recorded at fair value are as follows:
| As of July 31, 2024 | As of July 31, 2025 | |||
|---|---|---|---|---|
| CarryingValue | EstimatedFairValue | CarryingValue | EstimatedFairValue | |
| (in thousands) | ||||
| 2027 Notes | $570,073 | $631,178 | $497,059 | $695,295 |
| 2029 Notes | — | — | 846,759 | 976,652 |
| Total | $570,073 | $631,178 | $1,343,818 | $1,671,947 |
The carrying value of the 2027 Notes as of July 31, 2024 and 2025 was net of unamortized debt issuance costs of $4.9 million and $2.9 million, respectively.
The carrying value of the 2029 Notes as of July 31, 2025 was net of unamortized debt issuance costs of $15.7 million.
The total estimated fair values of the Notes were determined based on the closing trading price per $100 of the Notes as of the last day of trading for the period. We consider the fair values of the Notes to be Level II valuations due to the limited trading activity.
NOTE 4. BALANCE SHEET COMPONENTS
Short-Term Investments
The amortized cost of our short-term investments approximates their fair value. Unrealized losses related to our short-term investments are generally due to interest rate fluctuations, as opposed to credit quality. However, we review individual securities that are in an unrealized loss position in order to evaluate whether or not they have experienced or are expected to experience credit losses that would result in a decline in fair value. As of July 31, 2024 and 2025, unrealized gains and losses from our short-term investments were not material and were not the result of a decline in credit quality. As a result, as of July 31, 2024 and 2025, we didnot record any credit losses for these investments.
The following table summarizes the estimated fair value of our investments in marketable debt securities by their contractual maturity dates:
| (in thousands) | |
|---|---|
| Due within one year | $551,451 |
| Due in one to three years | 671,783 |
| Total | $1,223,234 |
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consists of the following:
| As of | ||
|---|---|---|
| July 31,2024 | July 31,2025 | |
| (in thousands) | ||
| Prepaid operating expenses | $62,815 | $56,762 |
| VAT receivables | 8,017 | 10,316 |
| Other current assets | 26,475 | 38,313 |
| Total prepaid expenses and other current assets | $97,307 | $105,391 |
Property and Equipment, Net
Property and equipment, net consists of the following:
| As of | |||
|---|---|---|---|
| EstimatedUseful Life | July 31,2024 | July 31,2025 | |
| (in months) · (in thousands) | |||
| Computer, production, engineering and other equipment | 36 | $421,559 | $435,564 |
| Demonstration units | 12 | 59,570 | 59,475 |
| Leasehold improvements | (1) | 64,607 | 71,520 |
| Software | (2) | 29,014 | 29,152 |
| Furniture and fixtures | 60 | 16,169 | 15,542 |
| Total property and equipment, gross | 590,919 | 611,253 | |
| Less: accumulated depreciation | (454,739) | (468,439) | |
| Total property and equipment, net | $136,180 | $142,814 | |
(1)
Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term.
(2)
The estimated useful life of software ranges from 36 to 120 months, representing the period during which the software is expected to contribute, either directly or indirectly, to our future cash flows.
Depreciation expense related to our property and equipment was $63.3 million, $65.6 million and $66.3 million for the fiscal years ended July 31, 2023, 2024 and 2025, respectively.
Intangible Assets, Net
Intangible assets, net consists of the following:
| As of | ||
|---|---|---|
| July 31,2024 | July 31,2025 | |
| (in thousands) | ||
| Developed technology | $79,838 | $79,838 |
| Customer relationships | 11,230 | 11,230 |
| Trade name | 4,200 | 4,200 |
| Total intangible assets, gross | 95,268 | 95,268 |
| Less: | ||
| Accumulated amortization of developed technology | (76,804) | (78,989) |
| Accumulated amortization of customer relationships | (9,111) | (9,464) |
| Accumulated amortization of trade name | (4,200) | (4,200) |
| Total accumulated amortization | (90,115) | (92,653) |
| Total intangible assets, net | $5,153 | $2,615 |
Amortization expense related to our intangible assets is recognized in our consolidated statements of operations within product cost of revenue for developed technology and sales and marketing expense for customer relationships and trade name. Amortization expense was $10.7 million, $3.7 million and $2.5 million for the fiscal years ended July 31, 2023, 2024 and 2025, respectively.
The changes in the net book value of intangible assets, net are as follows:
| As of July 31, | ||
|---|---|---|
| 2024 | 2025 | |
| (in thousands) | ||
| Intangible assets, net—beginning balance | $4,893 | $5,153 |
| Amortization of intangible assets (1) | (3,709) | (2,538) |
| Acquisition of intangible assets | 3,969 | — |
| Intangible assets, net—ending balance | $5,153 | $2,615 |
(1)
Represents amortization expense related to intangible assets recognized during the year in our consolidated statements of operations, within product cost of revenue and sales and marketing expense.
The estimated future amortization expense of our intangible assets is as follows:
| Fiscal Year Ending July 31: | Amount |
|---|---|
| (in thousands) | |
| 2026 | $778 |
| 2027 | 778 |
| 2028 | 353 |
| 2029 | 353 |
| 2030 | 353 |
| Total | $2,615 |
Goodwill
The changes in the carrying amount of goodwill are as follows:
| Carrying Amount | |
|---|---|
| (in thousands) | |
| Balance at July 31, 2023 | $184,938 |
| Adjustment for acquisition | 297 |
| Balance at July 31, 2024 | 185,235 |
| Balance at July 31, 2025 | $185,235 |
Accrued Compensation and Benefits
Accrued compensation and benefits consists of the following:
| As of | ||
|---|---|---|
| July 31,2024 | July 31,2025 | |
| (in thousands) | ||
| Accrued commissions and taxes | $40,714 | $51,036 |
| Accrued bonus | 17,863 | 37,654 |
| Payroll taxes payable | 31,797 | 31,366 |
| Accrued vacation | 26,772 | 31,062 |
| Contributions to ESPP withheld | 24,676 | 26,325 |
| Accrued wages and taxes | 16,255 | 18,846 |
| Accrued benefits | 16,580 | 17,976 |
| Other | 20,945 | 16,233 |
| Total accrued compensation and benefits | $195,602 | $230,498 |
NOTE 5. DEBT
2023 Notes
In January 2018, we issued the 2023 Notes with a 0% interest rate for an aggregate principal amount of $575.0 million, due in 2023, in a private placement to qualified institutional buyers pursuant to Rule144A under the Securities Act.
On September 22, 2021, we consummated privately negotiated exchanges with certain holders of the outstanding 2023 Notes, pursuant to which such holders exchanged approximately $416.5 million in aggregate principal amount of 2023 Notes for $477.3 million in aggregate principal amount of 2027 Notes. We also entered into privately negotiated transactions with certain holders of the 2023 Notes pursuant to which we repurchased approximately $12.8 million in aggregate principal amount of 2023 Notes for cash. Following the closing of these exchanges and repurchases, approximately $145.7 million in aggregate principal amount of 2023 Notes remained outstanding with terms unchanged.
In January 2023, we settled the 2023 Notes in full at maturity with a cash payment of $145.7 million.
2026 Notes
In September 2020, we issued $750.0 million in aggregate principal amount of the 2026 Notes to BCPE Nucleon (DE) SPV, LP, an entity affiliated with Bain Capital, LP ("Bain") (the "2026 Notes"). The 2026 Notes bore interest at a rate of 2.50% per annum, with such interest paid in kind ("PIK") on the 2026 Notes held by Bain through an increase in the principal amount of the 2026 Notes, and that would have been paid in cash on any 2026 Notes transferred to entities that are not affiliated with Bain. Interest on the 2026 Notes accrued from the date of issuance, September 24, 2020, and was added to the principal amount on a semi-annual basis (on March 15 and September 15 of each year).
On June 6, 2024, Bain delivered a notice of conversion to convert $817.6 million aggregate principal amount of the 2026 Notes, representing all of the outstanding principal amount as of that date. Under the terms of the indenture governing the 2026 Notes, the conversion was settled by paying the $817.6 million principal amount in cash and delivering the conversion spread of approximately 16.9 million shares of our Class A common stock. The cash portion was settled using a portion of our existing cash, cash equivalents and short-term investments.
The 2026 Notes were converted in accordance with their original terms and conditions. Upon conversion, because the carrying amount of the conversion option was previously reclassified to equity, the unamortized discount remaining at the date of conversion was recognized as interest expense. The remaining carrying amount of the 2026 Notes was reduced by the cash transferred and then recognized in equity, such that no gain or loss was recognized. In addition, the accrued and unpaid interest as of the conversion date was forgiven pursuant to the terms of the indenture and recognized in equity.
The following table sets forth the total interest expense recognized related to the 2026 Notes:
| Fiscal Year Ended July 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| (in thousands) | |||
| Interest expense related to amortization of debt discount | $36,668 | $35,955 | $— |
| Interest expense related to amortization of debt issuance costs | 4,189 | 4,107 | — |
| Non-cash interest expense | 19,757 | 18,550 | — |
| Interest expense related to conversion of 2026 Notes attributable to debt discount and issuance costs | — | 107,877 | — |
| Total interest expense | $60,614 | $166,489 | $— |
Non-cash interest expense was related to the 2.5% PIK interest that we accrued from the issuance of the 2026 Notes through the conversion date and was recognized within other expense, net in our consolidated statement of operations and other liabilities–non-current in our consolidated balance sheet. The accrued PIK interest was converted to the principal balance of the 2026 Notes at each payment date.
2027 Notes
In September 2021, we issued $575.0 million in aggregate principal amount of 0.25% convertible senior notes due 2027 consisting of (i) approximately $477.3 million principal amount of 2027 Notes in exchange for approximately $416.5 million principal amount of the previously outstanding 0% convertible senior notes due 2023 (the "2023 Notes") and (ii) approximately $97.7 million principal amount of 2027 Notes for cash.
In December 2024, we issued $862.5 million in aggregate principal amount of 0.50% convertible senior notes due 2029, discussed below. We used approximately $95.5 million of the net proceeds from the offering to repurchase $75.0 million aggregate principal amount of the outstanding 2027 Notes. The repurchase of $75.0 million aggregate principal amount of the outstanding 2027 Notes for approximately $95.5 million was accounted for as an induced conversion in accordance with ASU 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20). The induced conversion resulted in the recognition of an inducement expense of $11.3 million within other income (expense), net in our consolidated statement of operations and a reduction to equity of $9.7 million. Subsequent to the completion of this transaction, we had outstanding $500.0 million aggregate principal amount of the 2027 Notes.
The 2027 Notes bear interest at a rate of 0.25% per annum, and pay interest semi-annually in arrears on each April 1 and October 1. The 2027 Notes will mature on October 1, 2027, unless earlier converted, redeemed or repurchased.
The 2027 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of Class A common stock, at our election. Each $1,000 of principal of the 2027 Notes is initially convertible into 17.3192 shares of our Class A common stock, which is equivalent to an initial conversion price of approximately $57.74 per share, subject to customary anti-dilution adjustments. Holders of these 2027 Notes may convert their 2027 Notes at their option at any time prior to the close of the business day immediately preceding July 1, 2027, only under the following circumstances:
(1)
during any fiscal quarter, and only during such fiscal quarter, if the closing price of our common stock for at least 20 trading days in a period of 30 consecutive trading days ending on, and including, the last trading day of the preceding fiscal quarter is greater than or equal to 130% of the then applicable conversion price for the 2027 Notes per share of common stock;
(2)
during the five business day period after any consecutive five trading day period in which, for each trading day of that period, the trading price per $1,000 principal amount of 2027 Notes for such trading day was less than 98% of the product of the closing price of our common stock and the then applicable conversion rate on each such trading day;
(3)
if we call any or all of the 2027 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date, but only with respect to the 2027 Notes called (or deemed called) for redemption; or
(4)
upon the occurrence of certain specified corporate events.
Upon conversion of the 2027 Notes, we will pay or deliver, as the case may be, cash, shares of our Class A common stock or a combination of cash and shares of Class A common stock, at our election.
The conversion rate will be subject to adjustment in certain events, but will not be adjusted for any accrued or unpaid interest. Holders who convert their 2027 Notes in connection with certain corporate events that constitute a "make-whole fundamental change" (as defined in the indenture governing the 2027 Notes) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, if we undergo a "fundamental change" (as defined in the indenture governing the 2027 Notes) prior to the maturity date, holders of the 2027 Notes may require us to repurchase for cash all or a portion of their 2027 Notes at a repurchase price equal to 100% of the principal amount of the repurchased 2027 Notes, plus accrued and unpaid interest thereon.
In accounting for the exchange of convertible notes, we evaluated whether the transaction should be treated as a modification or extinguishment transaction. The partial exchange of the 2023 Notes and issuance of the 2027 Notes were deemed to have substantially different terms due to the significant difference between the value of the conversion option immediately prior to and after the exchange, and consequently, the 2023 Notes partial exchange was accounted for as a debt extinguishment. The $64.9 million difference between the total reacquisition price paid and the net carrying amount of the 2023 Notes was recognized as a debt extinguishment loss within other expense, net in our consolidated statement of operations.
The 2027 Notes consisted of the following:
| As of | ||
|---|---|---|
| July 31,2024 | July 31,2025 | |
| (in thousands) | ||
| Principal amounts: | ||
| Principal | $575,000 | $500,000 |
| Unamortized debt issuance costs (1) | (4,927) | (2,941) |
| Net carrying amount | $570,073 | $497,059 |
(1)
Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52%.
As of July 31, 2025, the remaining life of the 2027 Notes was approximately 2.2 years.
The following table sets forth the total interest expense recognized related to the 2027 Notes:
| Fiscal Year Ended July 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| (in thousands) | |||
| Contractual interest expense | $1,720 | $1,352 | $1,321 |
| Interest expense related to amortization of debt issuance costs | 1,530 | 1,538 | 1,420 |
| Total interest expense | $3,250 | $2,890 | $2,741 |
2029 Notes
In December 2024, we issued $862.5 million in aggregate principal amount of 0.50% convertible senior notes due 2029, including the exercise in full by the initial purchasers of the 2029 Notes of their option to purchase an additional $112.5 million principal amount, in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The total net proceeds from the offering were approximately $844.6 million, after deducting the initial purchasers’ discount and other debt issuance costs.
We used approximately $95.5 million of the net proceeds from the offering to repurchase $75.0 million aggregate principal amount of the outstanding 2027 Notes and approximately $200.0 million of the net proceeds from the offering to repurchase approximately 3.1 million shares of our Class A common stock.
The 2029 Notes bear interest at a rate of 0.50% per annum, payable semi-annually in arrears on each June 15 and December 15, beginning June 15, 2025. The 2029 Notes will mature on December 15, 2029, unless earlier converted, redeemed or repurchased.
The 2029 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of Class A common stock, at our election. Each $1,000 of principal of the 2029 Notes is initially convertible into 11.6505 shares of our Class A common stock, which is equivalent to an initial conversion price of approximately $85.83 per share, subject to customary anti-dilution adjustments. Holders of these 2029 Notes may convert them at their option at any time prior to the close of the business day immediately preceding September 15, 2029, only under the following circumstances:
(1)
during any fiscal quarter commencing after April 30, 2025, and only during such fiscal quarter, if the closing price of our common stock for at least 20 trading days in a period of 30 consecutive trading days ending on and including the last trading day of the preceding fiscal quarter is greater than or equal to 130% of the then applicable conversion price for the 2029 Notes per share of common stock;
(2)
during the five business day period after any consecutive five trading day period in which, for each trading day of that period, the trading price per $1,000 principal amount of 2029 Notes was less than 98% of the product of the closing price of our common stock and the then applicable conversion rate on each such trading day;
(3)
if we call any or all of the 2029 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date, but only with respect to the 2029 Notes called (or deemed called) for redemption; or
(4)
upon the occurrence of certain specified corporate events.
Upon conversion of the 2029 Notes, we will pay or deliver, as the case may be, cash, shares of our Class A common stock or a combination of cash and shares of Class A common stock, at our election.
The conversion rate will be subject to adjustment in certain events, but will not be adjusted for any accrued or unpaid interest. Holders who convert their 2029 Notes in connection with certain corporate events that constitute a "make-whole fundamental change" (as defined in the indenture governing the 2029 Notes) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, if we undergo a "fundamental change" (as defined in the indenture governing the 2029 Notes) prior to the maturity date, holders of the 2029 Notes may require us to repurchase for cash all or a portion of their 2029 Notes at a repurchase price equal to 100% of the principal amount of the repurchased 2029 Notes, plus accrued and unpaid interest thereon.
The 2029 Notes consisted of the following:
| As of | |
|---|---|
| (in thousands) | |
| Principal amounts: | |
| Principal | $862,500 |
| Unamortized debt issuance costs (1) | (15,741) |
| Net carrying amount | $846,759 |
(1)
Included in our consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2029 Notes using the effective interest rate method. The effective interest rate is 0.93%.
As of July 31, 2025, the remaining life of the 2029 Notes was approximately 4.4 years.
The following table sets forth the total interest expense recognized related to the 2029 Notes:
| Fiscal Year Ended July 31, | |
|---|---|
| (in thousands) | |
| Contractual interest expense | $2,695 |
| Interest expense related to amortization of debt issuance costs | 2,196 |
| Total interest expense | $4,891 |
Revolving Credit Agreement
In February 2025, we entered into a revolving credit agreement (the "Revolver") that provides for a senior secured revolving credit facility in an aggregate principal amount of $500.0 million, including a $25.0 million sublimit for the issuance of letters of credit. The Revolver matures in February 2030, subject to earlier springing maturity under certain circumstances.
Borrowings, if any, under the Revolver will bear interest, at our option, at a base rate plus an applicable margin ranging from 0.25% to 1.25% based upon our total leverage ratio or a term Secured Overnight Financing Rate (or an alternative currency term rate) plus an applicable margin ranging from 1.25% to 2.25% based upon our total leverage ratio. We are also required to pay a commitment fee on the unused portion of the Revolver on a quarterly basis equal to 0.175% to 0.30%, depending on our total leverage ratio.
The Revolver contains customary affirmative and negative covenants (including a financial covenant and restrictions on liens, investments, indebtedness, fundamental changes, restricted payments, transactions with affiliates, prepayments of subordinated debt and other matters, all subject to certain exceptions). The financial covenant requires us to maintain a total leverage ratio of less than or equal to 3.75:1.00, tested at the end of each fiscal quarter. The financial covenant is subject to a 0.50:1.00 step-up for four fiscal quarters following a material acquisition (as defined in the Revolver). As of July 31, 2025, we were in compliance with the financial covenant associated with the Revolver.
As of July 31, 2025, we hadno borrowings and an immaterial amount of letters of credit outstanding under the Revolver.
NOTE 6. LEASES
We have operating leases for offices, research and development facilities and data centers and finance leases for certain data center equipment. Our leases have remaining lease terms ofone year to approximately five years, some of which include options to renew or terminate. We do not include renewal options in the lease terms for calculating our lease liability, as we are not reasonably certain that we will exercise these renewal options at the time of the lease commencement. Our lease agreements do not contain any residual value guarantees or restrictive covenants.
Total operating lease cost was $42.4 million, $38.6 millionand $37.7 million for the fiscal years ended July 31, 2023, 2024 and 2025, respectively, excluding short-term lease costs, variable lease costs and sublease income, each of which were not material. Variable lease costs primarily include common area maintenance charges. Total finance lease cost was $3.9 million, $4.8 million, and $4.5 million for the fiscal years ended July 31, 2023, 2024 and 2025, respectively.
During fiscal 2023, we signed agreements to early exit certain office spaces in the United States and the Netherlands. The reductions in the lease terms resulted in decreases to the carrying amounts of the operating lease liabilities and the operating lease right-of-use assets on our consolidated balance sheet as of July 31, 2023. In addition, we recorded $1.7 million of expense in our consolidated statement of operations for the fiscal year ended July 31, 2023.
Supplemental balance sheet information related to our leases is as follows:
| As of | ||
|---|---|---|
| July 31,2024 | July 31,2025 | |
| (in thousands) | ||
| Operating leases: | ||
| Operating lease right-of-use assets, gross | $180,843 | $217,060 |
| Accumulated amortization | (71,710) | (82,534) |
| Operating lease right-of-use assets, net | $109,133 | $134,526 |
| Operating lease liabilities—current | $24,163 | $23,234 |
| Operating lease liabilities—non-current | 90,359 | 115,754 |
| Total operating lease liabilities | $114,522 | $138,988 |
| Weighted average remaining lease term (in years): | 4.8 | 4.5 |
| Weighted average discount rate: | 6.4% | 6.3% |
| As of | ||
|---|---|---|
| July 31,2024 | July 31,2025 | |
| (in thousands) | ||
| Finance leases: | ||
| Finance lease right-of-use assets, gross (1) | $19,345 | $18,288 |
| Accumulated amortization (1) | (9,412) | (12,805) |
| Finance lease right-of-use assets, net (1) | $9,933 | $5,483 |
| Finance lease liabilities—current (2) | $3,954 | $3,301 |
| Finance lease liabilities—non-current (3) | 6,666 | 2,734 |
| Total finance lease liabilities | $10,620 | $6,035 |
| Weighted average remaining lease term (in years): | 2.9 | 2.0 |
| Weighted average discount rate: | 7.0% | 7.1% |
(1)
Included in our consolidated balance sheets within property and equipment, net.
(2)
Included in our consolidated balance sheets within accrued expenses and other current liabilities.
(3)
Included in our consolidated balance sheets within other liabilities—non-current.
Supplemental cash flow and other information related to our leases is as follows:
| Fiscal Year Ended July 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| (in thousands) | |||
| Cash paid for amounts included in the measurement of lease liabilities: | |||
| Operating cash flows from operating leases | $46,886 | $39,973 | $37,419 |
| Operating cash flows from finance leases | $— | $885 | $614 |
| Financing cash flows from finance leases | $4,757 | $3,601 | $3,922 |
| Lease liabilities arising from obtaining right-of-use assets: | |||
| Operating leases | $10,358 | $46,153 | $54,435 |
| Finance leases | $7,827 | $1,066 | $— |
The undiscounted cash flows for our lease liabilities as of July 31, 2025 were as follows:
| Fiscal Year Ending July 31: | Operating Leases | Finance Leases | Total |
|---|---|---|---|
| (in thousands) | |||
| 2026 | $31,573 | $3,618 | $35,191 |
| 2027 | 37,052 | 1,908 | 38,960 |
| 2028 | 36,521 | 961 | 37,482 |
| 2029 | 33,232 | 42 | 33,274 |
| 2030 | 22,574 | — | 22,574 |
| Thereafter | 234 | — | 234 |
| Total lease payments | 161,186 | 6,529 | 167,715 |
| Less: imputed interest | (22,198) | (494) | (22,692) |
| Total lease obligation | 138,988 | 6,035 | 145,023 |
| Less: current lease obligations | (23,234) | (3,301) | (26,535) |
| Long-term lease obligations | $115,754 | $2,734 | $118,488 |
As of July 31, 2025, we had additional operating lease commitments of approximately $7.5 million on an undiscounted basis for certain office leases that have not yet commenced. These operating leases will commence during fiscal 2025, with lease terms of approximately five years.
NOTE 7. COMMITMENTS AND CONTINGENCIES
Purchase Commitments
In the normal course of business, we make commitments with our contract manufacturers to ensure them a minimum level of financial consideration for their investment in our joint solutions. These commitments are based on performance targets or on-hand inventory and non-cancelable purchase orders for non-standard components. We record a charge related to these items when we determine that it is probable a loss will be incurred and we are able to estimate the amount of the loss. Our historical charges have not been material. As of July 31, 2025, we had approximately$146.5 million of non-cancelable purchase obligations and other commitments pertaining to our daily business operations, and approximately$106.9 million in the form of guarantees to certain of our contract manufacturers.
Guarantees and Indemnifications
We have entered into agreements with some of our Partners and customers that contain indemnification provisions in the event of claims alleging that our products infringe the intellectual property rights of a third party. The scope of such indemnification varies, and may include, in certain cases, the ability to cure the indemnification by modifying or replacing the product at our own expense, requiring the return and refund of the infringing product, procuring the right for the partner and/or customer to continue to use or distribute the product, as applicable, and/or defending the partner or customer against and paying any damages from third-party actions based upon claims of infringement. Other guarantees or indemnification arrangements include guarantees of product and service performance.
We have also agreed to indemnify our directors, executive officers and certain other officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by us, arising out of that person’s services as a director or officer of our company or that person’s services provided to any other company or enterprise at our request. We maintain director and officer insurance coverage that may enable us to recover a portion of any future amounts paid.
The fair value of liabilities related to indemnifications and guarantee provisions are not material and have not had any material impact on our consolidated financial statements to date.
We are not currently a party to any legal proceedings that we believe to be material to our business or financial condition. From time to time, we may become party to various litigation matters and subject to claims that arise in the ordinary course of business.
NOTE 8. STOCKHOLDERS’ EQUITY
We haveone class of outstanding common stock consisting of Class A common stock. As of July 31, 2025, we had 1.0 billion shares of Class A common stock authorized, with a par value of $0.000025 per share. As of July 31, 2025, wehad 269.0 million shares of Class A common stock issued and outstanding. As of July 31, 2025, we had 0.2 million shares of preferred stock authorized, with a par value of $0.000025 per share, andno shares issued and outstanding.
Holders of Class A common stock are entitled toone vote for each share of Class A common stock held on all matters submitted to a vote of stockholders.
Share Repurchases
In August 2023, our Board of Directors authorized the repurchase of up to $350.0 million of our Class A common stock. In August 2025, our Board of Directors approved a $350.0 million increase to the share repurchase authorization. Repurchases may be made from time to time through open market purchases, in through privately negotiated transactions or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Exchange Act in accordance with applicable securities laws and other restrictions. The authorization has no expiration date, may be modified, suspended or discontinued at any time, and does not obligate us to repurchase any minimum number of shares.
During the fiscal year ended July 31, 2024, we repurchased approximately 2.6 million shares of Class A common stock in open market transactions at a weighted average price of $50.77 per share for an aggregate purchase price of approximately $131.1 million. During the fiscal year ended July 31, 2025, we repurchased approximately 1.6 million shares of Class A common stock in open market transactions at a weighted average price of $68.25 per share for an aggregate purchase price of approximately $107.4 million. As of July 31, 2025, approximately $111.5 million remained available for future share repurchases under the authorization.
In December 2024, we used approximately $200.0 million of the net proceeds from the 2029 Notes offering to repurchase approximately 3.1 million shares of our Class A common stock in privately negotiated transactions at a purchase price equal to $64.78 per share. This share repurchase was executed outside of the existing share repurchase program that was authorized by our Board of Directors in August 2023, described above. For additional details on this transaction, refer to Note 5.
Common Stock Reserved for Issuance
As of July 31, 2025, we had reserved shares of common stock for future issuance as follows:
| (in thousands) | |
|---|---|
| Shares reserved for future equity grants | 32,438 |
| Shares underlying outstanding stock options | 8 |
| Shares underlying outstanding restricted stock units | 16,245 |
| Shares reserved for future employee stock purchase plan awards | 9,187 |
| Total | 57,878 |
NOTE 9. EQUITY INCENTIVE PLANS
Stock Plans
We haveone active equity incentive plan, the 2016 Equity Incentive Plan (the "2016 Plan"), andtwo inactive equity incentive plans, the 2010 Stock Plan ("2010 Plan") and the 2011 Stock Plan ("2011 Plan") (collectively, the "Stock Plans"). Our stockholders approved the 2016 Plan in March 2016 and it became effective in connection with our initial public offering ("IPO"). As a result, at the time of the IPO, we ceased granting additional stock awards under the 2010 Plan and 2011 Plan and both plans were terminated. Any outstanding stock awards under the 2010 Plan and 2011 Plan remain outstanding, subject to the terms of the applicable plan and award agreements, until such shares are issued under those stock awards, by exercise of stock options or settlement of RSUs, or until those stock awards become vested or expired by their terms.
Under the 2016 Plan, we may grant incentive stock options, non-statutory stock options, restricted stock, RSUs, and stock appreciation rights to employees, directors and consultants. We initially reserved approximately 22.4 million shares of our Class A common stock for issuance under the 2016 Plan. The number of shares of Class A common stock available for issuance under the 2016 Plan also includes an annual increase on the first day of each fiscal year, beginning in fiscal 2018, equal to the lesser of:18.0 million shares,5% of the outstanding shares of all classes of common stock as of the last day of our immediately preceding fiscal year, or such other amount as may be determined by our Board of Directors. Accordingly, on August 1, 2023 and 2024, the number of shares of Class A common stock available for issuance under the 2016 Plan increased by approximately 12.0 million and 13.3 million shares, respectively, pursuant to these provisions. As of July 31, 2025, we had reserved a total of approximately 48.7 million shares for the issuance of equity awards under the Stock Plans, of which approximately 32.4 million shares were still available for grant. On August 1,2025, the number of shares of Class A common stock available for issuance under the 2016 Plan increased by approximately 13.5 million shares pursuant to the automatic increase provisions.
Restricted Stock Units
RSUs settle into shares of Class A common stock upon vesting. During the second quarter of fiscal 2024, we began funding withholding taxes due on the vesting of employee RSUs by net share settlement, rather than our previous approach of selling shares of Class A common stock to cover taxes upon vesting of such awards. The payment of the withheld taxes to the tax authorities is reflected as a financing activity within the consolidated statements of cash flows.
Performance RSUs
From time to time, we grant RSUs that have both service and performance conditions to our executives and employees ("PRSUs"). Vesting of PRSUs is subject to continuous service and the satisfaction of certain performance targets. While we recognize cumulative stock-based compensation expense for the portion of the awards for which both the service condition has been satisfied and it is probable that the performance conditions will be met, the actual vesting and settlement of PRSUs are subject to the performance conditions actually being met.
In January 2024, the Compensation Committee of our Board of Directors approved the grant of approximately 0.3 million PRSUs to our President and CEO. These PRSUs have a grant date fair value per unit of $45.86 and will vest up to 200% based on achievement of specified annual recurring revenue and free cash flow hurdles over a performance period of approximately 3.6 years, subject to his continuous service as CEO through the vesting date.
Market Stock Units
We also grant RSUs that have both service and market-based conditions to our executives and employees ("MSUs"). Vesting of MSUs is subject to continuous service and the satisfaction of certain market-based performance targets. While we recognize cumulative stock-based compensation expense for the portion of the awards for which the service condition has been satisfied, regardless of achievement of the specified targets, the actual vesting and settlement of MSUs are subject to the market-based conditions actually being met.
During fiscal 2023, 2024 and 2025, the Compensation Committee of our Board of Directors approved the grant of approximately 1.3 million,0.8 million and 0.4 million MSUs, respectively, to certain of our executives. These MSUs have a weighted average grant date fair value per unit of approximately $27.89, $47.65 and $93.40, respectively, and will vest up to 200% of the target number of MSUs based upon our total shareholder return relative to the total shareholder return of companies in the Nasdaq Composite Index over a performance period of approximately 3.1 years,3.0 years and 3.0 years, respectively, subject to continuous service on each vesting date.
In January 2024, the Compensation Committee of our Board of Directors approved the grant of approximately 0.2 million MSUs to our President and CEO. These MSUs have a weighted average grant date fair value of $62.85 per unit and will vest up to 200% based on achievement of specified stock price hurdles at any time during a performance period of approximately 3.6 years, subject to his continuous service as CEO through the vesting date.
Below is a summary of RSU activity and PRSU and MSU (collectively, "PSU") activity under the Stock Plans:
| RSUs | PSUs | |||
|---|---|---|---|---|
| Number ofShares | Weighted AverageGrant Date Fair Value per Share | Number ofShares | Weighted AverageGrant Date Fair Value per Share | |
| (in thousands) · (in thousands) | ||||
| Outstanding at July 31, 2022 | 20,876 | $29.34 | 1,260 | $38.71 |
| Granted | 16,045 | $19.25 | 1,339 | $27.89 |
| Released | (9,938) | $27.28 | (314) | $34.07 |
| Forfeited | (4,169) | $26.36 | (325) | $30.08 |
| Outstanding at July 31, 2023 | 22,814 | $23.69 | 1,960 | $33.49 |
| Granted | 9,850 | $34.22 | 1,396 | $49.82 |
| Released | (10,844) | $25.76 | (796) | $25.25 |
| Forfeited | (1,959) | $25.73 | (246) | $45.15 |
| Outstanding at July 31, 2024 | 19,861 | $27.58 | 2,314 | $44.94 |
| Granted (1) | 5,658 | $61.62 | 711 | $86.81 |
| Released (1) | (9,526) | $30.16 | (1,140) | $42.46 |
| Forfeited | (1,562) | $34.63 | (72) | $52.48 |
| Outstanding at July 31, 2025 | 14,431 | $38.46 | 1,813 | $62.63 |
(1)
For PSUs, includes additional shares granted upon vesting due to achievement over 100%.
The aggregate grant date fair value of RSUs, including PSUs, vested was $281.8 million, $299.5 million and $335.7 million for the fiscal years ended July 31, 2023, 2024 and 2025, respectively.
Stock Options
Our Board of Directors determines the period over which stock options become exercisable and stock options generally vest over afour-year period. Stock options generally expire 10 years from the date of grant. The term of an ISO grant to a 10% stockholder will not exceed five years from the date of the grant. The exercise price of an ISO will not be less than 100% of the estimated fair value of the shares of common stock underlying the stock option (or 110% of the estimated fair value in the case of an ISO granted to a 10% stockholder) on the date of grant. The exercise price of an NSO is determined by our Board of Directors at the time of grant and is generally not less than 100% of the estimated fair value of the shares of common stock underlying the stock option on the date of grant.
Below is a summary of stock option activity under the Stock Plans:
| Fiscal Year Ended July 31, | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 · 2025 | ||||||||||
| Number ofShares · WeightedAverageExercisePrice · WeightedAverageRemainingContractualLife · AggregateIntrinsicValue · Number ofShares · WeightedAverageExercisePrice · WeightedAverageRemainingContractualLife · AggregateIntrinsicValue | ||||||||||
| (in thousands) · (in years) · (in thousands) · (in thousands) · (in years) · (in thousands) | ||||||||||
| Outstanding at beginning of period | 1,046 | $6.83 | 1.1 | $24,451 | 258 | $11.26 | 0.7 | $10,138 | ||
| Options granted | — | $— | — | $— | ||||||
| Options exercised | (788) | $5.38 | (250) | $11.20 | ||||||
| Options canceled/forfeited | — | $— | — | $— | ||||||
| Outstanding at end of period | 258 | $11.26 | 0.7 | $10,138 | 8 | $13.11 | 0.7 | $492 | ||
| Exercisable at end of period | 258 | $11.26 | 0.7 | $10,138 | 8 | $13.11 | 0.7 | $492 | ||
The aggregate intrinsic value of stock options exercised during the fiscal years ended July 31, 2023, 2024 and 2025 was $12.1 million, $37.8 million and $13.9 million, respectively. Aggregate intrinsic value represents the difference between the exercise price of the options and the estimated fair value of our common stock. Cash received from option exercises was $3.7 million, $4.2 million and $2.8 million for the fiscal years ended July 31, 2023, 2024 and 2025, respectively. There were no stock options that vested during the fiscal years ended July 31, 2023, 2024 or 2025. We didnot grant any stock options during the fiscal years ended July 31, 2023, 2024 or 2025.
Employee Stock Purchase Plan
In December 2015, our Board of Directors adopted the 2016 Employee Stock Purchase Plan, which was subsequently amended in January 2016 and September 2016 and approved by our stockholders in March 2016 (the "Original 2016 ESPP"). The Original 2016 ESPP became effective in connection with our IPO. Our stockholders subsequently approved amendments to the Original 2016 ESPP in December 2019 and December 2022 (as amended, the "2016 ESPP"). Under the 2016 ESPP, the maximum number of shares of Class A common stock available for sale is 13.8 million shares.
The 2016 ESPP allows eligible employees to purchase shares of our Class A common stock at a discount through payroll deductions of up to 15% of eligible compensation, subject to caps of $25,000 in any calendar year and 1,000 shares on any purchase date. The 2016 ESPP provides for 12-month offering periods, generally beginning in March and September of each year, and each offering period consists oftwo six-month purchase periods.
On each purchase date, participating employees will purchase Class A common stock at a price per share equal to 85% of the lesser of the fair market value of our Class A common stock on (i) the first trading day of the applicable offering period or (ii) the last trading day of each purchase period in the applicable offering period. If the stock price of our Class A common stock on any purchase date in an offering period is lower than the stock price on the enrollment date of that offering period, the offering period will immediately reset after the purchase of shares on such purchase date and automatically roll into a new offering period.
During the fiscal year ended July 31, 2025, approximately 1.6 million shares of common stock were purchased under the 2016 ESPP for an aggregate amount of approximately $66.1 million. As of July 31, 2025, approximately 9.2 million shares were available for future issuance under the 2016 ESPP.
We use the Black-Scholes option pricing model to determine the fair value of shares purchased under the 2016 ESPP with the following weighted average assumptions on the date of grant:
| Fiscal Year Ended July 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| Expected term (in years) | 0.74 | 0.78 | 0.72 |
| Risk-free interest rate | 4.3% | 5.1% | 4.9% |
| Volatility | 59.8% | 47.2% | 46.2% |
| Dividend yield | —% | —% | —% |
Total stock-based compensation expense recognized in our consolidated statements of operations is as follows:
| Fiscal Year Ended July 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| (in thousands) | |||
| Cost of revenue: | |||
| Product | $7,966 | $6,822 | $2,824 |
| Support, entitlements and other services | 26,611 | 27,285 | 27,582 |
| Sales and marketing | 82,758 | 80,190 | 80,930 |
| Research and development | 139,073 | 156,784 | 175,361 |
| General and administrative | 55,337 | 62,752 | 64,893 |
| Total stock-based compensation expense | $311,745 | $333,833 | $351,590 |
As of July 31, 2025, unrecognized stock-based compensation expense related to outstanding stock awards was approximately $560.5 million and is expected to be recognized over a weighted average period of approximately 2.0 years.
NOTE 10. RESTRUCTURING CHARGES
In August 2022, we announced a plan to reduce our global headcount by approximately 270 employees, which represented approximately 4% of our total employees, following a review of our business structure and after taking other cost-cutting measures to reduce expenses. This headcount reduction was part of our efforts to drive toward profitable growth.
We recognized total restructuring charges of approximately $16.3 million, which consisted primarily of one-time severance and other termination benefit costs directly related to this reduction in force. Of the approximately $16.3 million recognized, $0.4 million is included within support, entitlements and other services cost of revenue, $13.4 million is included within sales and marketing expense, $2.3 million is included within research and development expense, and $0.2 million is included within general and administrative expense on our consolidated statements of operations.
During the fiscal year ended July 31, 2023, we recognized restructuring charges of approximately $5.3 million and made cash payments of approximately $15.8 million. During the fiscal year ended July 31, 2024, we didnot incur any charges and made cash payments of approximately $0.4 million. During the fiscal year ended July 31, 2025, we didnot incur any charges or make any cash payments. As of July 31, 2025, we had no remaining restructuring liability.
NOTE 11. NET INCOME (LOSS) PER SHARE
Basic net income (loss) per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by giving effect to potentially dilutive common stock equivalents outstanding during the period, as their effect would be dilutive. Potentially dilutive common shares include shares issuable upon the exercise of stock options, the vesting of RSUs and PSUs, each purchase under the 2016 ESPP, and common stock issuable upon the conversion of convertible debt under the if-converted method.
In loss periods, basic net loss per share and diluted net loss per share are the same, as the effect of potential common shares is antidilutive and therefore excluded.
The computation of basic and diluted net income (loss) per share attributable to common stockholders is as follows:
| Fiscal Year Ended July 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| (in thousands, except per share data) | |||
| Numerator: | |||
| Net (loss) income | $(254,560) | $(124,775) | $188,366 |
| Add: Interest expense related to convertible senior notes, net of tax | — | — | 3,173 |
| Diluted net (loss) income | $(254,560) | $(124,775) | $191,539 |
| Denominator: | |||
| Weighted average shares, basic | 233,247 | 244,743 | 267,479 |
| Add: Dilutive effect of common stock equivalents | — | — | 26,604 |
| Weighted average shares, diluted | 233,247 | 244,743 | 294,083 |
| Net (loss) income per share attributable to Class A common stockholders, basic | $(1.09) | $(0.51) | $0.70 |
| Net (loss) income per share attributable to Class A common stockholders, diluted | $(1.09) | $(0.51) | $0.65 |
The following shares of common stock were excluded from the computation of diluted net income (loss) per share for the periods presented, as their effect would have been antidilutive:
| Fiscal Year EndedJuly 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| (in thousands) | |||
| Outstanding stock options, RSUs and PSUs | 25,820 | 22,433 | 839 |
| Employee stock purchase plan | 1,122 | 1,148 | 64 |
| Common stock issuable upon the conversion of convertible notes | 38,700 | 39,423 | — |
| Total | 65,642 | 63,004 | 903 |
Shares that will be issued in connection with our stock awards and shares that will be purchased under the employee stock purchase plan are generally automatically converted into shares of our Class A common stock. Common stock issuable upon the conversion of convertible notes represents the antidilutive impact of the 2026 Notes and 2027 Notes under the if-converted method.
NOTE 12. INCOME TAXES
(Loss) income before provision for income taxes by fiscal year consisted of the following:
| Fiscal Year Ended July 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| (in thousands) | |||
| Domestic | $(294,093) | $(167,745) | $118,516 |
| Foreign | 60,508 | 66,427 | 93,132 |
| (Loss) income before provision for income taxes | $(233,585) | $(101,318) | $211,648 |
Provision for income taxes by fiscal year consisted of the following:
| Fiscal Year Ended July 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| (in thousands) | |||
| Current: | |||
| U.S. federal | $(568) | $— | $1,489 |
| State and local | 623 | 2,052 | 3,774 |
| Foreign | 21,952 | 23,925 | 21,657 |
| Total current taxes | 22,007 | 25,977 | 26,920 |
| Deferred: | |||
| U.S. federal | 24 | 24 | 24 |
| Foreign | (1,056) | (2,544) | (3,662) |
| Total deferred taxes | (1,032) | (2,520) | (3,638) |
| Provision for income taxes | $20,975 | $23,457 | $23,282 |
The income tax provision differs from the amount of income tax determined by applying the applicable U.S. federal statutory income tax rate of 21% to pre-tax loss. The reconciliation of the statutory federal income tax and our effective income tax is as follows:
| Fiscal Year Ended July 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| (in thousands) | |||
| U.S. federal income tax at statutory rate | $(49,053) | $(21,277) | $44,446 |
| Change in valuation allowance | 71,157 | 115,826 | 89,264 |
| Stock-based compensation | 8,767 | (47,632) | (67,782) |
| Effect of foreign operations | (4,896) | (2,553) | (7,111) |
| Research and development tax credits | (17,500) | (30,076) | (41,597) |
| Non-deductible expenses | 5,090 | 4,704 | 3,413 |
| Change in unrecognized tax benefit | 1,840 | 2,840 | (4,977) |
| State income taxes | 623 | 2,052 | 3,774 |
| Tax impact of Frame divestiture | 4,569 | — | — |
| Tax impact of debt conversion | — | — | 2,383 |
| Other | 378 | (427) | 1,469 |
| Total | $20,975 | $23,457 | $23,282 |
During the fiscal years ended July 31, 2023, 2024 and 2025, our provision for income taxes was primarily attributable to foreign tax provisions in certain foreign jurisdictions in which we conduct business.
The temporary differences that give rise to significant portions of deferred tax assets and liabilities are as follows:
| As of July 31, | ||
|---|---|---|
| 2024 | 2025 | |
| (in thousands) | ||
| Deferred tax assets: | ||
| Net operating loss carryforward | $532,559 | $416,176 |
| Tax credit carryforward | 292,546 | 365,828 |
| Capitalized research expenses | 241,194 | 356,927 |
| Deferred revenue | 179,093 | 213,308 |
| Leases | 35,416 | 41,364 |
| Accruals and reserves | 25,065 | 30,940 |
| Stock-based compensation | 17,221 | 17,573 |
| Intangibles and goodwill | 8,447 | 8,044 |
| Property and equipment | 4,302 | — |
| Other assets | 22,631 | 26,434 |
| Total deferred tax assets | 1,358,474 | 1,476,594 |
| Deferred tax liabilities: | ||
| Deferred commission expense | (84,409) | (79,757) |
| Leases | (36,100) | (41,294) |
| Prepaid expenses | (2,249) | (2,387) |
| Intangibles and goodwill | (1,394) | (1,504) |
| Property and equipment | (1,359) | (911) |
| Other | (14,075) | (15,984) |
| Total deferred tax liabilities | (139,586) | (141,837) |
| Valuation allowance | (1,205,780) | (1,318,056) |
| Net deferred tax assets | $13,108 | $16,701 |
Management believes that based on available evidence, both positive and negative, it is more likely than not that the U.S. deferred tax assets will not be utilized and as such, a full valuation allowance has been recorded.
The valuation allowance for deferred tax assets was $1.3 billion as of July 31, 2025. The net increase in the total valuation allowance for the fiscal years ended July 31, 2024 and 2025 was $127.4 million and $112.3 million, respectively.
As of July 31, 2025, we had approximately $1.8 billion of federal net operating loss carryforwards and $1.5 billion of state net operating loss carryforwards available to reduce future taxable income, which will begin to expire in fiscal 2026. In addition, we had approximately $219.0 million of federal research credit carryforwards, $160.2 million of state research credit carryforwards and $63.6 million of foreign tax credit carryforwards available to reduce future tax liability. The federal credits will begin to expire in fiscal 2035 and the state credits can be carried forward indefinitely. The foreign credits will begin to expire in fiscal 2029.
Utilization of the net operating loss and tax credit carryforwards may be subject to an annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended, and similar state provisions. Any annual limitation may result in the expiration of net operating losses and credits before utilization. If an ownership change occurred, utilization of the net operating loss and tax credit carryforwards could be significantly reduced.
As of July 31, 2025, we held an aggregate of $331.2 million in cash and cash equivalents in our foreign subsidiaries, of which $156.8 million was denominated in U.S. dollars. We attribute net revenue, costs and expenses to domestic and foreign components based on the terms of our agreements with our subsidiaries. We do not provide for federal income taxes on the undistributed earnings of our foreign subsidiaries, as such earnings are to be reinvested offshore indefinitely. It is not practicable to estimate the withholding tax liability if these earnings were to be repatriated.
We recognize uncertain tax positions in our financial statements if that position will more likely than not be sustained on audit, based on the technical merits of the position. A reconciliation of our unrecognized tax benefits, excluding accrued interest and penalties, is as follows:
| Fiscal Year Ended July 31, | ||
|---|---|---|
| 2024 | 2025 | |
| (in thousands) | ||
| Balance at the beginning of the year | $95,862 | $102,647 |
| Increases related to current year tax positions | 7,595 | 9,651 |
| Increases related to prior year tax positions | 425 | 1,670 |
| Decreases related to prior year tax positions | (932) | (144) |
| Lapse of statute of limitations/Settlements/Other | (303) | (3,646) |
| Balance at the end of the year | $102,647 | $110,178 |
During the fiscal year ended July 31, 2025, the net increase in unrecognized tax positions was primarily attributable to federal and state research and development credits and intercompany charges.
As of July 31, 2025, if uncertain tax positions are fully recognized in the future, it would result in a $17.5 million impact to our effective tax rate, primarily relating to positions in foreign jurisdictions, and the remaining amount would result in adjustments to deferred tax assets and corresponding adjustments to the valuation allowance.
We recognize interest and/or penalties related to income tax matters as a component of income tax expense. As of July 31, 2025, we had recognized $7.8 million of accrued interest and penalties related to uncertain tax positions.
We file income tax returns in the U.S. federal jurisdiction as well as various U.S. states and foreign jurisdictions. The tax years 2009 and forward remain open to examination by the major jurisdictions in which we are subject to tax. These fiscal years outside the normal statute of limitation remain open to audit by tax authorities due to tax attributes generated in those early years, which have been carried forward and may be audited in subsequent years when utilized. We are subject to the continuous examination of income tax returns by various tax authorities. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the provision for income taxes. We believe that adequate amounts have been reserved for any adjustments that may ultimately result from these examinations. We do not anticipate a significant impact to the gross unrecognized tax benefits within the next 12 months related to these years.
The Organisation for Economic Co-operation and Development has established a framework for a global minimum corporate tax of 15%, known as Pillar Two, which will be applied on a country-by-country basis to companies with global revenues and profits above certain thresholds. Although the United States has not enacted legislation to adopt Pillar Two, and its future adoption is uncertain, several countries where we operate have enacted such legislation, and others are in the process of doing so. We do not expect Pillar Two to have a material impact on our effective tax rate or our financial condition and results of operations.
The One Big Beautiful Bill Act ("OBBBA") includes significant changes to U.S. income tax laws, including the repeal of mandatory capitalization of domestic research and development expenditures, extensions of bonus depreciation, and modifications to the international tax regimes. We are currently evaluating the potential impact of OBBBA on our consolidated financial statements for future periods.
NOTE 13. SEGMENT INFORMATION
Our chief operating decision maker ("CODM") is our Chief Executive Officer, who reviews financial information presented on a consolidated basis. Accordingly, we have a single operating and reportable segment. The CODM uses net income, as reported on our consolidated statements of operations, as the measure of segment profit or loss to allocate resources and evaluate financial performance. The significant expenses regularly provided to the CODM are those expenses presented in our consolidated statements of operations and related notes to consolidated financial statements. There is no expense or asset information that is supplemental to the information disclosed in these consolidated financial statements.
The following table sets forth revenue by geographic location based on bill-to location:
| Fiscal Year Ended July 31, | |||
|---|---|---|---|
| 2023 | 2024 | 2025 | |
| (in thousands) | |||
| United States | $1,039,294 | $1,189,213 | $1,409,367 |
| Europe, the Middle East and Africa | 471,367 | 563,281 | 685,569 |
| Asia Pacific | 309,138 | 348,952 | 392,744 |
| Other Americas | 43,096 | 47,370 | 50,247 |
| Total revenue | $1,862,895 | $2,148,816 | $2,537,927 |
For the fiscal years ended July 31, 2023, 2024 and 2025, no individual country, other than the United States, accounted for more than 10% of total revenue.
The following table sets forth long-lived assets, which primarily include property and equipment, net, by geographic location:
| As of | ||
|---|---|---|
| July 31,2024 | July 31,2025 | |
| (in thousands) | ||
| United States | $102,873 | $108,921 |
| International | 33,307 | 33,893 |
| Total long-lived assets | $136,180 | $142,814 |
NOTE 14. SUBSEQUENT EVENT
In August 2025, our Board of Directors approved a $350.0 million increase to the share repurchase authorization. Repurchases may be made from time to time through open market purchases, in privately negotiated transactions or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Exchange Act in accordance with applicable securities laws and other restrictions. The authorization has no expiration date, may be modified, suspended or discontinued at any time, and does not obligate us to repurchase any minimum number of shares.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.